Articles with keyword PD-1
-
Neoadjuvant anti PD-1 / PD-L1 immune checkpoint inhibitors in locall y advanced gastric cancer with microsatellite insta bility
A.Y. Navmatulya, V.A. Chubenko, S.A. Savchuk, F.R. Almukhametova, P.Y. Tsuprun, A.I. Kuznetsov, G.S. Inusilaev, V.A. Heinstein, K.V. Shelekhova, Е.М. Zykov, B.I. Miroshnikov, V.M. Moiseenko
Gastric cancer, immune checkpoint inhibitors, MSI, microsatellite instability, PD-1, PD-L1, objective response, pathologic response.
-
Immune checkpoint inhibitors in the treatment of cervical cancer: literature review
O.A. Pardabekova
cervical cancer, immunotherapy, immune checkpoint inhibitors, pd-1,
-
Immuno-related adverse events of checkpoint inhibitors
G.Yu. Kharkevich, K.V. Orlova
immune-related adverse events, skin toxicity, colitis, hepatitis,anti-CTLA-4, anti-PD-1, hypophysitis, melanoma
-
Biomarkers predicting the effect of immunotherapy: what you need to know in practice?
A.M. Konstantinova
immunotherapy, CTLA-4, PD-1, PD-L1, microsatellite instability, mutation burden, tumor-infiltrating lymphocytes, biomarkers, efficacy.
-
Efficacy of immune checkpoints inhibitors in the treatment of solid tumors
A.A. Rumyantsev, S.A. Tjulandin
drug therapy, immunotherapy, CTLA-4, PD-1, PD-L1, check-points, programmed cell death protein, nivolumab, pembrolizumab, ipilimumab, atezolizumab, biomarkers, efficacy